Clinical Trial Update: Treatment of Peripheral Neuropathy in Patients With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a treatment for peripheral neuropathy in patients with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathies, Diabetes Mellitus | Phase 3 | Status: COMPLETED